FDA Drug recall D-1186-2014
Suprax, Cefixime for Oral Suspension USP 500 mg/5 ml, 10mL (when reconstituted), Rx only, Manufactured for Lupin Pharmaceuticals, Inc. 111…
- FDA Drug
- Class III
- terminated
- Published 2014-04-09
On 2014-04-09 the FDA classified a Class III recall of Suprax, Cefixime for Oral Suspension USP 500 mg/5 ml, 10mL (when reconstituted), Rx only, Manufactured for Lupin Pharmaceuticals, Inc. 111… by Lupin Pharmaceuticals, citing failed Impurities/Degradation Specifications: Product did not meet specification in total impurities at the 9-month stability station.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1186-2014 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2014-01-27 |
| Published | 2014-04-09 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Lupin Pharmaceuticals |
| Distribution | US |
Product
Suprax, Cefixime for Oral Suspension USP 500 mg/5 ml, 10mL (when reconstituted), Rx only, Manufactured for Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, MD 21202, Manufactured by Lupin Limited Mumbai 400 058 India, NDC 27437-207-02.
Reason
Failed Impurities/Degradation Specifications: Product did not meet specification in total impurities at the 9-month stability station.
Identifiers
| code_info | Lot #s: F300737 Exp. February 2015, F300743 Exp. February 2015 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1186-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.